Alto Neuroscience, Inc. (“Alto”) (NYSE: ANRO), a clinical-stage biopharmaceutical company focused on the development of novel precision medicines for neuropsychiatric disorders, today reported ...
Financial firms such as Oppenheimer (1), Citigroup (2) and Goldman Sachs (3) have been raising their S&P 500 value ...
Dire economic forecast: Robert Kiyosaki warns the US faces a 'Greater Depression' driven by debt, inflation and a fragile financial system. Mixed signals so far: Gold and Bitcoin have surged, but ...
2don MSNOpinion
The man who predicted the last crash says something much worse is coming — are you prepared?
America’s $38.9 trillion national debt is now reshaping how millions think about money, retirement and survival. Robert ...
Detailed price information for Gh Research Plc (GHRS-Q) from The Globe and Mail including charting and trades.
As of May 2026, despite many Americans struggling, the nation has not fallen into a recession, let alone a “greater” ...
US large-cap index is up about 250% over the last ten years, compared to a 70% gain for the FTSE 100 and a measly 35% gain ...
Learn how economic forecasting uses GDP, inflation, and key indicators to project future economic trends and inform business ...
Confirmatory Phase 3 trial of roluperidone for negative symptoms of schizophrenia initiated and first patient screenedPrevious open label trial ...
ALTO-207 is a fixed-dose combination of pramipexole, a dopamine D3/D2 agonist with antidepressant activity demonstrated across multiple prior studies, and ondansetron, a 5-HT3 antagonist anti-emetic.
As the Iran war spills over into everyday life, Americans say they are worse off than at most any point in the last 25 years.
TOKYO--(BUSINESS WIRE)--Renesas Electronics Corporation (TSE: 6723), a premier supplier of advanced semiconductor solutions, today announced the consolidated financial forecasts for the six months ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results